Sunday, 1 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Fund Raise

Eurotex Industries & Exports Fund Raise

Eurotex Industries and Exports Ltd submitted its Regulation 32 compliance report for the period ended March 31, 2026. The company confirmed that no funds were raised through rights or preferential issues during the year, resulting in no material deviation or variation in fund utilization.

Source

BSE filing, NSE: EUROTEXIND. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Eurotex Industries & Exports Ltd: key numbers

Share price
₹11.58
Market cap
₹10.13 Cr
Revenue (annual)
₹0.11 Cr
Net profit (annual)
₹-0.79 Cr
P/E (TTM)
-8.2×Sector 50.0×
Promoter holding
70.99%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Eurotex Industries & Exports Ltd

All →

Other fund raise announcements

All →
20:28 IST BSE
Fund RaiseSudarshan Pharma Industries Ltd SUDARSHAN

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value
₹72.00 Cr
19:27 IST NSE
Fund RaiseFlywings Simulator Training Centre Ltd FWSTC

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value
₹68.20 Cr
16:20 IST BSE
Fund RaiseKanel Industries Ltd KANELOIL

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value
₹16.99 Cr
Execution
Rights issue opens 23 November 2026 and closes 30 November 2026
15:05 IST BSE
Fund RaiseSudarshan Pharma Industries Ltd SUDARSHAN

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.